about
Recent insights into the molecular pathogenesis of Crohn's disease: a review of emerging therapeutic targetsAdipose-Derived Mesenchymal Stem Cells Restore Impaired Mucosal Immune Responses in Aged MiceEfficacy of Mesenchymal Stromal Cells for Fistula Treatment of Crohn's Disease: A Systematic Review and Meta-Analysis.Rejuvenation of mucosal immunosenescence by adipose tissue-derived mesenchymal stem cells.Ex Vivo Induced Regulatory Human/Murine Mesenchymal Stem Cells as Immune Modulators.
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Cell therapy of refractory Crohn's disease.
@en
Cell therapy of refractory Crohn's disease.
@nl
type
label
Cell therapy of refractory Crohn's disease.
@en
Cell therapy of refractory Crohn's disease.
@nl
prefLabel
Cell therapy of refractory Crohn's disease.
@en
Cell therapy of refractory Crohn's disease.
@nl
P2093
P2860
P1476
Cell therapy of refractory Crohn's disease.
@en
P2093
A G Konoplyannikov
A I Parfenov
I N Ruchkina
O V Knyazev
P L Shcherbakov
P2860
P2888
P304
P356
10.1007/S10517-013-2297-8
P577
2013-11-01T00:00:00Z